Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Maxcyte, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 120 | +5 |
| Shares | 66.1M | 14.5K | 64.3M | −1.75M (−2.6%) |
| Value | $303.3M | $64.7K | $200.8M | −$102.5M (−33.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Maxcyte, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 476,605 | $1.49M | 0.00% |
| Maven Securities LTD | 204,175 | $637.0K | 0.07% |
| Diametric Capital, LP | 51,524 | $160.8K | 0.07% |
| SG Americas Securities, LLC | 37,750 | $118.0K | 0.00% |
| Qube Research & Technologies Ltd | 30,911 | $96.4K | 0.00% |
| Chilton Investment Co LLC | 21,933 | $68.4K | 0.00% |
| Prelude Capital Management, LLC | 16,540 | $51.6K | 0.00% |
| AQR Capital Management LLC | 15,864 | $49.5K | 0.00% |
| Envestnet Asset Management Inc | 14,740 | $46.0K | 0.00% |
| Pictet Asset Management Holding SA | 14,535 | $45.2K | 0.00% |
| Aigen Investment Management, LP | 14,169 | $44.2K | 0.01% |
| Johnson Investment Counsel Inc | 10,815 | $33.7K | 0.00% |
| State of Wisconsin Investment Board | 10,677 | $32.5K | 0.00% |
| Victory Capital Management Inc | 10,010 | $31.2K | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,630 | $5.09K | 0.00% |
| Quantbot Technologies LP | 153 | $477 | 0.00% |
| Grove Bank & Trust | 67 | $209 | 0.00% |
Sold out (12)
Institutions that held Maxcyte, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Artisan Partners Limited Partnership | 1,243,493 | $5.71M |
| Captrust Financial Advisors | 208,448 | $956.8K |
| Valmark Advisers, Inc. | 163,056 | $748.4K |
| Moors & Cabot, Inc. | 26,969 | $123.8K |
| 1492 Capital Management LLC | 16,321 | $74.9K |
| Two Sigma Investments, LP | 15,661 | $71.9K |
| Squarepoint Ops LLC | 14,173 | $65.1K |
| Fox Run Management, L.L.C. | 13,510 | $62.0K |
| Cerity Partners LLC | 12,510 | $57.7K |
| Harbor Capital Advisors, Inc. | 5,652 | $25.9K |
| Quadrant Capital Group LLC | 81 | $372 |
| CWM, LLC | 33 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Maxcyte, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 14,535 | $64.7K |